Table 2.
Bioanalytical methods for the quantification of vitamin K in Human Urine
Analytes | Quantification method |
Bio- matrix |
Bio-matrix volume |
Internal standard |
Linearity | Limit of detection |
References |
---|---|---|---|---|---|---|---|
Vitamin K3 (Menadione) | UPLC-ESI-MS/MS | Human plasma and urine | 1.0 mL | MD-d8 | 0.05-50.0 ng/mL | 0.03 ng/mL for plasma 0.02 ng/mL for urine | (25) |
Vitamin K3 (Menadione) | LC-APCI-MS/MS | Human urine, rat plasma, human culture d cell and media | Urine: 0.5 mL Plasma: 0.5 mL Cultured cell and media: 1-5 mL |
MD-d8 | Up to 50 ng/40 μL or 50 ng per injection | MD: 40 pg/40 μL MD-d8: 2 pg/40 μL | (70) |
Vitamin K3 (Menadione) | HPLC-FD | Urine | 0.5 mL | MK-2 | 0-3.64 pmole | LLOQ: 0.3 pmole/ml | (39) |
Urinary metabolites of vitamin K | HPLC-ECD | Urine | Unsupplemented: 0.5 mL Supplemented: 0.05 mL |
2-methyl-3-(7’-carboxyheptyl)-1,4-naphthoquin one | N/A | <3.5 fmol (<1 pg) | (48) |
Vitamin K1,K2,K3,A,D3,E,E-acetate,ε-tocopherol | HPLC-PDA | Human serum and urine | 0.1 mL | Xanthophyll | Up to 25 ng/μL | 0.03 ng/μL-VK1 0.33 ng/μL-VK2 0.33 ng/μL-VK3 | (50) |